文献速递血栓与止血

深静脉血栓患者中肺栓塞的遗传关联:国际静脉血栓反对联盟研究

Genetic associations with pulmonary embolism among those with a deep vein thrombosis: the International Network Against Venous Thrombosis Consortium.
PubMed 文献 · J Thromb Haemost · 2026-07-27

该研究采用病例仅设计,在静脉血栓栓塞症(VTE)患者中比较肺栓塞(PE)与孤立性深静脉血栓(DVT)的遗传差异。对29项研究共126 316例VTE患者(54 389例PE,71 927例孤立性DVT)进行全基因组关联研究(GWAS)荟萃分析,发现4个复制成功的变异与PE风险相关,多基因风险评分每增加1个标准差与PE风险相关(OR 1.05)。结论支持在假定DVT背景下PE受遗传调控,但总体效应 modest。

要点

  • F5 rs6025(因子V Leiden)与PE风险降低相关(OR 0.66)。
  • FGG rs2066864、F11 rs4253417与PE风险轻度升高相关,SLC12A2-DT rs3749748与风险降低相关。
  • 多基因风险评分每增加1个标准差,PE风险OR为1.05(95%CI 1.003-1.094)。

核心结论

  • 在假定DVT的VTE患者中,PE的发生受遗传因素调控,但总体效应 modest。

研究设计与样本

  • 病例仅设计,在VTE患者中比较PE(伴或不伴临床报告的DVT)与孤立性DVT。
  • 对国际静脉血栓反对联盟29项研究的GWAS进行荟萃分析,共126 316例VTE患者(PE 54 389例,孤立性DVT 71 927例)。
  • 采用逻辑回归模型(以PE为结局对比孤立性DVT)进行变异发现和复制分析,并构建多基因风险评分。
  • 基于GWAS发现估计进行转录组广泛关联研究分析。

主要发现

  • 发现阶段5个变异达到全基因组显著性(P < 5 × 10-8),其中4个在复制阶段成功。
  • 复制成功的变异:F5 rs6025(因子V Leiden)OR 0.66;FGG rs2066864 OR 1.08;F11 rs4253417 OR 1.07;SLC12A2-DT rs3749748 OR 0.92。
  • 多基因风险评分每增加1个标准差与PE风险相关(OR 1.05;95% CI 1.003-1.094)。
  • 转录组广泛关联研究分析发现FGG、SLC12A2-DT和CDHR4转录本的遗传关联。

关键数值与推荐

  • 全基因组显著性阈值P < 5 × 10-8。
  • F5 rs6025 OR 0.66;FGG rs2066864 OR 1.08;F11 rs4253417 OR 1.07;SLC12A2-DT rs3749748 OR 0.92。
  • 多基因风险评分每1 SD增加OR 1.05(95% CI 1.003-1.094)。

临床怎么用

  • 对于VTE患者,可考虑F5、FGG、F11等遗传变异及多基因风险评分辅助评估PE风险,但效应量较小,需结合临床综合判断。

局限性

  • 研究采用病例仅设计,无法评估遗传因素对VTE总体风险的影响。
  • 总体遗传效应 modest,临床效用有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Venous thromboembolism (VTE) includes deep vein thrombosis (DVT) and pulmonary embolism (PE), the latter of which often originates from DVT and can be fatal. OBJECTIVES: The aim of this study was to identify causal genetic factors that alter risk of PE among those with a presumed DVT. METHODS: Using a case-only design of VTE, we conducted meta-analyses of genome-wide association studies (GWASs) in the International Network Against Venous Thrombosis Consortium. Among participants diagnosed with VTE, each study identified those who had a clinically reported PE, with or without a clinically reported DVT; those remaining had isolated DVT. Logistic regression models (PE as outcome compared with isolated DVT) were used for variant discovery and replication analyses. A polygenic risk score was created from the GWAS findings. Transcriptome-wide association study analyses were conducted using the GWAS discovery estimates. RESULTS: Our discovery and replication analyses included 126 316 individuals with a VTE across 29 studies: 54 389 who had a PE and the remaining 71 927 who had an isolated DVT. Five variants reached genome-wide significance (P < 5 × 10-8) in discovery, 4 of which replicated: F5 rs6025 (factor V Leiden), odds ratio (OR) 0.66; FGG rs2066864, OR 1.08; F11 rs4253417, OR 1.07; and SLC12A2-DT rs3749748, OR 0.92. Each 1 SD increase in the polygenic risk score was associated with risk (OR: 1.05; 95% CI: 1.003-1.094). Transcriptome-wide association study analysis identified genetic associations with FGG, SLC12A2-DT, and CDHR4 transcripts. CONCLUSION: Although the overall risk for VTE is strongly heritable, our findings support the hypothesis that PE in the setting of a presumed DVT is regulated by genetics, although the overall effect appears modest.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Lozano-Esparza S, Shakt GE, Brody JA, et al. Genetic associations with pulmonary embolism among those with a deep vein thrombosis: the International Network Against Venous Thrombosis Consortium. J Thromb Haemost. 2026. PMID: 42508647. doi:10.1016/j.jtha.2026.06.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。